Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Rituximab in Renal Transplantation
NCT01312064Phase 4Terminated
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus, rituximab in Renal Insufficiency (RI), sponsored by National Taiwan University Hospital. Started Apr 2011; status: terminated.
02
Drugs
everolimusrituximab
03
Conditions
Renal Insufficiency (RI)
Beyond the preview
Go deeper on NCT01312064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01312064.